Here's the thing None, and I mean none of these updates mean a darn thing to the market UNTIL we see either $ in financial statements to signal a milestone payment by AbbVie, an announcement that they are market launching, or $ are received for any of the other pipelines.
Once revenue becomes a reality here, then these updates will mean one heck of a lot more to the street. I believe that will be the sling shot effect that could very likely play out.
The hard part is those data points could come tomorrow, next months, years or never.
What I keep coming back to is why the CEO put $500k after-tax cash into a boat load more shares. He knows, maybe, and we don't.